Nusantara Sejahtera Raya Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp93 (market cap 7.75T, 1.98M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 22.7K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 25.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (1.98M versus 22.7K). Which is the better fit depends on your goals.
| CNMA | DGNS | |
|---|---|---|
Market Cap | 7.75T | 308B |
Volume | 1.98M | 22.7K |
Lot | 19.76K | 227 |
Turnover | 184.45M | 5.17M |
Average Price | 93.35 | 227.59 |
Value | 184.45M | 5.17M |
Indicative Equilibrium Price | 94 | 230 |
Indicative Equilibrium Volume | 1.17K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.
Read more on CNMA →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →